NLRP3 inflammasome gene expression have a negative correlation with REM sleep duration. This evidence suggest that NLRP3 inflammasome is involved in the pathogenesis of the sleep disorders. inhibitors of the NLRP3 inflammasome may be promising therapeutic agents in sleep deprivation and sleep fragmentation. This evidence concerns the gene NLRP3 and sleep disorder.